Records 1 - 5 (of 5 Records)
|Query Trace: Esophageal Neoplasms and ABCC2[original query]|
| A germline predictive signature of response to platinum chemotherapy in esophageal cancer.
Translational research : the journal of laboratory and clinical medicine 2015 Dec .
Rumiato Enrica, Boldrin Elisa, Malacrida Sandro, Battaglia Giorgio, Bocus Paolo, Castoro Carlo, Cagol Matteo, Chiarion-Sileni Vanna, Ruol Alberto, Amadori Alberto, Saggioro Danie
| ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Cancer chemotherapy and pharmacology 2020 Aug .
Nomura Hisanaga, Tsuji Daiki, Demachi Ken, Mochizuki Nobuo, Matsuzawa Haruki, Yano Tomonori, Daiko Hiroyuki, Fujii Satoshi, Kojima Takashi, Itoh Kunihiko, Kawasaki Toshikat
| Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy.
Esophagus : official journal of the Japan Esophageal Society 2021 Aug .
Fujita Kazuma, Motoyama Satoru, Sato Yusuke, Wakita Akiyuki, Nagaki Yushi, Minamiya Yoshihiro, Miura Masato
| Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
The journal of gene medicine 2022 Jun e3434.
Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi
| Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer.
Cancer chemotherapy and pharmacology 2023 10 .
Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: